Yong Qing Luo
Chief Executive Officer bei EVEREST MEDICINES LIMITED
Vermögen: 3 Mio $ am 31.03.2024
Profil
Yong Qing Luo is currently the Chief Executive Officer & Executive Director at Everest Medicines Ltd.
He is also the President & Executive Director at Brii Biosciences Ltd.
and the President & General Manager at Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Previously, Dr. Luo worked as an Associate Brand Director at Novartis AG from 2007 to 2009.
He then served as the President, Executive Director & GM-Greater China at Brii Biosciences Ltd.
(China) from 2020 to 2022.
From 2009 to 2012, he was the Head-Great China Pharmaceutical Organization at Beijing Novartis Pharma Co. Ltd.
He also held the position of Vice President at Shanghai Roche Pharmaceuticals Ltd.
from 2012 to 2016.
Prior to that, he worked as the Global Vice President & General Manager-China at Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd.
from 2016 to 2020.
Dr. Luo holds an MBA from China Europe International Business School, which he obtained in 2006.
He also has a doctorate degree from Xiangya School of Medicine, conferred in 1992.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EVEREST MEDICINES LTD.
0,30% | 05.04.2024 | 980 474 ( 0,30% ) | 3 Mio $ | 31.03.2024 |
BRII BIOSCIENCES LIMITED
-.--% | 15.09.2022 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Yong Qing Luo
| Unternehmen | Position | Beginn |
|---|---|---|
| EVEREST MEDICINES LIMITED | Chief Executive Officer | 19.09.2022 |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
 Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | President | 17.09.2020 |
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | President | - |
Ehemalige bekannte Positionen von Yong Qing Luo
| Unternehmen | Position | Ende |
|---|---|---|
| BRII BIOSCIENCES LIMITED | President | 15.09.2022 |
| Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd. | Corporate Officer/Principal | 01.09.2020 |
Shanghai Roche Pharmaceuticals Ltd.
 Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The private company is based in Shenchang, China. | Corporate Officer/Principal | 01.08.2016 |
Beijing Novartis Pharma Ltd.
 Beijing Novartis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Beijing Novartis Pharma Ltd. is a pharmaceutical company. The private company is based in Beijing, China. Founded in 1987, it operates in the pharmaceutical industry. | Corporate Officer/Principal | 01.08.2012 |
| NOVARTIS AG | Corporate Officer/Principal | 01.06.2009 |
Ausbildung von Yong Qing Luo
| China Europe International Business School | Masters Business Admin |
| Xiangya School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| EVEREST MEDICINES LIMITED | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Private Unternehmen | 5 |
|---|---|
Beijing Novartis Pharma Ltd.
Beijing Novartis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Beijing Novartis Pharma Ltd. is a pharmaceutical company. The private company is based in Beijing, China. Founded in 1987, it operates in the pharmaceutical industry. | Health Technology |
Shanghai Roche Pharmaceuticals Ltd.
Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The private company is based in Shenchang, China. | Health Technology |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | Health Technology |
| Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd. | |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
